Back

Endothelial cell-specific expression of Angiopoietin-2 leads to reduced thrombus resolution

26 August 2017 (12:35 - 13:25)
Organised by:
Add to my library
Congress Presentation Part of: Vascular degeneration and restoration Angiogenesis ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Lukas Hobohm

University Medical Center of Mainz, Mainz (Germany)

6 More presentations in this session

Presentation thumbnail
Ninjurin1 is a novel factor for vascular maturation and mediates the blood flow recovery in the hind limb ischemia.
Mr A. Minoshima (Asahikawa, JP)
Abstract Slides
Presentation thumbnail
Hyperglycemia potentiates the TGFbeta-induced endothelial to mesenchymal transition
Doctor E. Pardali (Munster, DE)
Abstract
Presentation thumbnail
A novel protein Senescence-associated glycoprotein (SAGP) is involved in the vessel homeostasis in murine hind limb ischemia model.
Doctor M. Suda (Tokyo, JP)
Abstract Slides
Presentation thumbnail
The pro-angiogenic effect of coronary serum after myocardial infarction on microvascular obstruction repair. Role of hypoxia-inducible factor-1A
Mr C. Rios Navarro (Valencia, ES)
Abstract Slides
Presentation thumbnail
Atherosclerosis reduction and improved glucose control the ABCA1 agonist CS6253. In vitro and in vivo mechanism of action studies
Doctor J. Johansson (San Francisco, US)
Abstract Slides

Access the full session

Session thumbnail
Vascular degeneration and restoration

The Event

Event poster

ESC Congress 2017

26 August 2017 12:35 CET
You may be interested in
thumbnail
Congress Presentation
Circulating Angiopoietin-2 (Angpt2) levels predict diagnosis of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
30 August 2024
thumbnail
Congress Presentation
JCAD enhances arterial thrombosis by regulating endothelial plasminogen activator inhibitor-1 and tissue factor expression
28 August 2021
thumbnail
Congress Session
Coagulation and treatment
19 May 2025
thumbnail
Congress Presentation
Restoration of endothelial glycocalyx is a promising therapeutic approach for heart failure
1 September 2025

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources